307 related articles for article (PubMed ID: 12746791)
1. Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.
Keiser PB; Nash TE
Clin Infect Dis; 2003 May; 36(10):e122-6. PubMed ID: 12746791
[TBL] [Abstract][Full Text] [Related]
2. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
Romo ML; Carpio A; Kelvin EA
J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis.
Mitre E; Talaat KR; Sperling MR; Nash TE
Clin Infect Dis; 2007 Feb; 44(4):549-53. PubMed ID: 17243058
[TBL] [Abstract][Full Text] [Related]
4. Drug treatment of neurocysticercosis.
Garg RK
Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
Kaur S; Singhi P; Singhi S; Khandelwal N
Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
Jung-Cook H
Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
[TBL] [Abstract][Full Text] [Related]
7. [Neurocysticercosis: up-dating in diagnosis and treatment].
Del Brutto OH
Neurologia; 2005 Oct; 20(8):412-8. PubMed ID: 16217690
[TBL] [Abstract][Full Text] [Related]
8. Medical management of neurocysticercosis.
Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
[TBL] [Abstract][Full Text] [Related]
9. Human Extraparenchymal Neurocysticercosis: The Control of Inflammation Favors the Host…but Also the Parasite.
Toledo A; Osorio R; Matus C; Martinez Lopez Y; Ramirez Cruz N; Sciutto E; Fragoso G; Arauz A; Carrillo-Mezo R; Fleury A
Front Immunol; 2018; 9():2652. PubMed ID: 30505305
[No Abstract] [Full Text] [Related]
10. Etanercept to Control Inflammation in the Treatment of Complicated Neurocysticercosis.
Nash TE; Ware JM; Coyle CM; Mahanty S
Am J Trop Med Hyg; 2019 Mar; 100(3):609-616. PubMed ID: 30608049
[TBL] [Abstract][Full Text] [Related]
11. Monitoring treatment of Taenia solium- neurocysticercosis by detection of circulating antigens: a case report.
Rodríguez-Hidalgo R; Carpio A; Van den Enden E; Benítez-Ortiz W
BMC Neurol; 2019 Apr; 19(1):52. PubMed ID: 30943908
[TBL] [Abstract][Full Text] [Related]
12. Neurocysticercosis an uncommon intra-cerebral infection in Malaysia.
Arasu K; Khairul A; Waran V
Med J Malaysia; 2005 Oct; 60(4):514-6. PubMed ID: 16570721
[TBL] [Abstract][Full Text] [Related]
13. Anticysticercal treatment and seizures in neurocysticercosis.
Singh G; Sander JW
Lancet Neurol; 2004 Apr; 3(4):207-8. PubMed ID: 15039032
[No Abstract] [Full Text] [Related]
14. Could neurocysticercosis be the cause of "onchocerciasis-associated" epileptic seizures?
Katabarwa M; Lakwo T; Habumogisha P; Richards F; Eberhard M
Am J Trop Med Hyg; 2008 Mar; 78(3):400-1. PubMed ID: 18337333
[TBL] [Abstract][Full Text] [Related]
15. Natural History of Treated Subarachnoid Neurocysticercosis.
Nash TE; O'Connell EM; Hammoud DA; Wetzler L; Ware JM; Mahanty S
Am J Trop Med Hyg; 2020 Jan; 102(1):78-89. PubMed ID: 31642423
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid use in neurocysticercosis.
Nash TE; Mahanty S; Garcia HH;
Expert Rev Neurother; 2011 Aug; 11(8):1175-83. PubMed ID: 21797658
[TBL] [Abstract][Full Text] [Related]
17. [About an autochtonous case of neurocysticercosis in Mali].
Maïga Y; Diallo M; Bouteille B; Konate A; Diarra M; Maïga M; Marjolet M
Bull Soc Pathol Exot; 2009 Oct; 102(4):211-4. PubMed ID: 19950534
[TBL] [Abstract][Full Text] [Related]
18. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
Cárdenas G; Carrillo-Mezo R; Jung H; Sciutto E; Hernandez JL; Fleury A
BMC Neurol; 2010 Mar; 10():16. PubMed ID: 20202200
[TBL] [Abstract][Full Text] [Related]
19. Medical management of neurocysticercosis.
Garg RK
Neurol India; 2001 Dec; 49(4):329-37. PubMed ID: 11799403
[TBL] [Abstract][Full Text] [Related]
20. [A case of neurocysticercosis presenting as focal seizure].
Sugiyama M; Okada T; Higuchi H; Yabe Y; Kobayashi N; Teramoto A
No Shinkei Geka; 2000 Sep; 28(9):807-10. PubMed ID: 11025881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
